These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 6380286)

  • 41. Free-from-failure survival in Hodgkin's disease. Long-term analysis of 148 cases treated with a MOPP-modified protocol.
    Silingardi V; Federico M; Frassoldati A; Barbieri F; Palomba G; Mauri C
    Acta Haematol; 1989; 82(4):179-86. PubMed ID: 2511719
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Site of relapse after chemotherapy alone for stage I and II Hodgkin's disease.
    Shahidi M; Kamangari N; Ashley S; Cunningham D; Horwich A
    Radiother Oncol; 2006 Jan; 78(1):1-5. PubMed ID: 16309770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease.
    Press OW; LeBlanc M; Lichter AS; Grogan TM; Unger JM; Wasserman TH; Gaynor ER; Peterson BA; Miller TP; Fisher RI
    J Clin Oncol; 2001 Nov; 19(22):4238-44. PubMed ID: 11709567
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of early stage Hodgkin's disease.
    Straus DJ
    Blood Rev; 1993 Mar; 7(1):34-42. PubMed ID: 8467230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hodgkin's disease. Our 9-year experience with the 1980 protocol].
    Marín J; Lasa R; Egurbide I; Etxebeste MA; Bengoetxea E; Angulo P; Antigüedad M; Furundarena JR; Peinado F; Navarro E
    Sangre (Barc); 1992 Feb; 37(1):11-6. PubMed ID: 1585232
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cure of early-stage Hodgkin's disease with subtotal nodal irradiation.
    Wasserman TH; Trenkner DA; Fineberg B; Kucik N
    Cancer; 1991 Sep; 68(6):1208-15. PubMed ID: 1873772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study.
    Biti GP; Cimino G; Cartoni C; Magrini SM; Anselmo AP; Enrici RM; Bellesi GP; Bosi A; Papa G; Giannarelli D
    J Clin Oncol; 1992 Mar; 10(3):378-82. PubMed ID: 1740677
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Partial instead of complete splenectomy in children for the pathological staging of Hodgkin disease].
    Hoekstra HJ; Tamminga RY; Timens W
    Ned Tijdschr Geneeskd; 1993 Nov; 137(48):2491-4. PubMed ID: 8272125
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hodgkin's disease in elderly patients (> or =60): clinical outcome and treatment strategies.
    Kim HK; Silver B; Li S; Neuberg D; Mauch P
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):556-60. PubMed ID: 12738333
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hodgkin's disease: study of treatment intensities and incidences of second malignancies.
    Rodriguez MA; Fuller LM; Zimmerman SO; Allen PK; Brown BW; Munsell MF; Hagemeister FB; McLaughlin P; Velasquez WS; Swan F
    Ann Oncol; 1993 Feb; 4(2):125-31. PubMed ID: 8448080
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
    Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
    Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and toxicity of vinblastine, bleomycin, and methotrexate with involved-field radiotherapy in clinical stage IA and IIA Hodgkin's disease: a British National Lymphoma Investigation pilot study.
    Bates NP; Williams MV; Bessell EM; Vaughan Hudson G; Vaughan Hudson B
    J Clin Oncol; 1994 Feb; 12(2):288-96. PubMed ID: 7509382
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Partial splenectomy in children: an alternative for splenectomy in the pathological staging of Hodgkin's disease.
    Hoekstra HJ; Tamminga RY; Timens W
    Ann Surg Oncol; 1994 Nov; 1(6):480-6. PubMed ID: 7850554
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
    Fermé C; Eghbali H; Meerwaldt JH; Rieux C; Bosq J; Berger F; Girinsky T; Brice P; van't Veer MB; Walewski JA; Lederlin P; Tirelli U; Carde P; Van den Neste E; Gyan E; Monconduit M; Diviné M; Raemaekers JM; Salles G; Noordijk EM; Creemers GJ; Gabarre J; Hagenbeek A; Reman O; Blanc M; Thomas J; Vié B; Kluin-Nelemans JC; Viseu F; Baars JW; Poortmans P; Lugtenburg PJ; Carrie C; Jaubert J; Henry-Amar M;
    N Engl J Med; 2007 Nov; 357(19):1916-27. PubMed ID: 17989384
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radio-therapy: analysis of efficacy and long-term toxicity.
    Brusamolino E; Lunghi F; Orlandi E; Astori C; Passamonti F; Baraté C; Pagnucco G; Baio A; Franchini P; Lazzarino M; Bernasconi C
    Haematologica; 2000 Oct; 85(10):1032-9. PubMed ID: 11025593
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.
    Carde P; Hagenbeek A; Hayat M; Monconduit M; Thomas J; Burgers MJ; Noordijk EM; Tanguy A; Meerwaldt JH; Le Fur R
    J Clin Oncol; 1993 Nov; 11(11):2258-72. PubMed ID: 7693881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hodgkin's disease; a regional retrospective study].
    Erdkamp FL; Wijlhuizen TJ; van Dam FE
    Ned Tijdschr Geneeskd; 1988 Sep; 132(39):1801-6. PubMed ID: 3141820
    [No Abstract]   [Full Text] [Related]  

  • 59. Controversies in the use of diagnostic staging laparotomy and splenectomy in the management of Hodgkin's disease.
    Mauch P; Somers R
    Ann Oncol; 1992 Sep; 3 Suppl 4():41-3. PubMed ID: 1450079
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results.
    Bonadonna G; Bonfante V; Viviani S; Di Russo A; Villani F; Valagussa P
    J Clin Oncol; 2004 Jul; 22(14):2835-41. PubMed ID: 15199092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.